Otlertuzumab

Ask supplier a question | View on supplier's website

Otlertuzumab is a humanized anti-CD37 monoclonal antibody developed for the cancer therapy. Otlertuzumab binds to CD37 on B-cells, which may result in antibody-dependent cell-mediated cytotoxicity (ADCC) and apoptosis.

Supplier	BOC Sciences
Product #	1372645-37-8
Pricing	Inquire
Cas	1372645-37-8

Feedback